DNA glycosylase fusion proteins (The Scripps Research Institute)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameDNA glycosylase fusion proteins (The Scripps Research Institute)
Drug Alias NameE2C-204E3-204
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsApoptosis stimulants
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A